| 2026 | | Durvalumab-containing treatment for recurrent or metastatic pulmonary sarcomatoid carcinoma: A pooled post hoc analysis of two KCSG phase II trials
Lung cancer (Amsterdam, Netherlands), 213. : 108916-108916, 2026 | 안미선 |
| 2025 | | Unveiling the clinical impact of plasma-only mutations in non-small cell lung cancer: a Korean multicenter experience
Translational lung cancer research, 14(11). : 4973-4982, 2025 | 안미선 |
| 2025 | | Real-world treatment outcomes in South Korean patients with epidermal growth factor receptor-mutant non-small cell lung cancer
The Korean journal of internal medicine, 40(6). : 1029-1041, 2025 | 김태환, 안미선, 이현우, 최용원, 최진혁 |
| 2025 | | Analysis of outcomes according to start timing of adjuvant chemotherapy in patients with gastric cancer: a retrospective nationwide cohort study
The oncologist, 30(6). : oyaf132-oyaf132, 2025 | 강석윤, 권민석, 김태환, 박범희, 안미선, 이현우, 최용원, 최진혁 |
| 2025 | | Target-Enhanced Whole-Genome Sequencing Shows Clinical Validity Equivalent to Commercially Available Targeted Oncology Panel
Cancer research and treatment, 57(2). : 350-361, 2025 | 권민석, 김석휘, 김장희, 김태환, 노진, 박준성, 안미선, 이현우, 최용원 |
| 2025 | | Phase 2 trial of avelumab in combination with gemcitabine in advanced leiomyosarcoma as a second-line treatment (EAGLES, Korean Cancer Study Group UN18-09)
Cancer, 131(1). : e35609-e35609, 2025 | 안미선 |
| 2024 | | Age- and ethnic-driven molecular and clinical disparity of East Asian breast cancers
BMC medicine, 22(1). : 422-422, 2024 | 안미선 |
| 2024 | | Clinical application of whole-genome sequencing of solid tumors for precision oncology
Experimental & molecular medicine, 56(8). : 1856-1868, 2024 | 강석윤, 고영화, 곽규성, 권민석, 김석휘, 김선일, 김세혁, 김장희, 김재근, 김창우, 김철호, 김태환, 노성현, 노진, 노충균, 박지원, 박지은, 백수연, 손상용, 신승수, 안미선, 양민재, 유우식, 윤재성, 이기명, 이길호, 이다근, 이현우, 임선교, 장전엽, 정윤정, 조대성, 최용원, 최진혁, 하태양, 한상욱, 허지미, 허훈 |
| 2024 | | Imatinib in c‑KIT‑mutated metastatic solid tumors: A multicenter trial of Korean Cancer Study Group (UN18‑05 Trial)
Journal of cancer research and therapeutics, 20(3). : 972-978, 2024 | 안미선 |
| 2024 | | Colon cancer: the 2023 Korean clinical practice guidelines for diagnosis and treatment
Annals of coloproctology, 40(2). : 89-113, 2024 | 안미선, 윤준기 |
| 2024 | | Differential efficacy of tyrosine kinase inhibitors according to the types of EGFR mutations and agents in non-small cell lung cancer: a real-world study
BMC cancer, 24(1). : 70-70, 2024 | 강석윤, 고영화, 김태환, 신승수, 안미선, 이현우, 최용원, 최진혁 |
| 2023 | | Thromboembolic events in patients who received adjuvant chemotherapy for gastric cancer: a single-center retrospective study
Gastric cancer, 26(6). : 1012-1019, 2023 | 강석윤, 권민석, 김태환, 손상용, 신승수, 안미선, 이현우, 최용원, 최진혁, 한상욱, 허훈 |
| 2023 | | A phase II study on the efficacy of regorafenib in treating patients with c-KIT-mutated metastatic malignant melanoma that progressed after previous treatment (KCSG-UN-14-13)
European journal of cancer (Oxford, England : 1990), 193. : 113312-113312, 2023 | 안미선 |
| 2023 | | Genomic analysis of plasma circulating tumor DNA in patients with heavily pretreated HER2 + metastatic breast cancer
Scientific reports, 13(1). : 9928-9928, 2023 | 안미선 |
| 2023 | | Safety and effectiveness of aflibercept in combination with FOLFIRI in Korean patients with metastatic colorectal cancer who received oxaliplatin-containing regimen
Journal of cancer research and clinical oncology, 149(3). : 1131-1143, 2023 | 안미선 |
| 2022 | | 237 (PB117) - A phase II study to evaluate the efficacy of regorafenib in C-KIT mutated metastatic malignant melanoma patients who have progressed on first-line treatment: A Multicenter Trial of Korean Cancer Study Group (UN-14–13)
European journal of cancer (Oxford, England : 1990), 174(S1). : S85-S86, 2022 | 안미선 |
| 2022 | | Comparison of the Data of a Next-Generation Sequencing Panel from K-MASTER Project with That of Orthogonal Methods for Detecting Targetable Genetic Alterations
Cancer research and treatment, 54(1). : 30-39, 2022 | 안미선 |
| 2022 | | The efficacy of EGFR-tyrosine kinase inhibitor in non-small cell lung cancer patients with synchronous brain metastasis: a real-world study
The Korean journal of internal medicine, 37(2). : 434-443, 2022 | 강석윤, 김세혁, 노오규, 노태훈, 신승수, 안미선, 오영택, 이현우, 최용원, 최진혁 |
| 2022 | | Erratum: Analysis of thromboembolic events in head and neck cancer patients who underwent concurrent chemoradiotherapy with cisplatin
The Korean journal of internal medicine, 37(6). : 1269-1269, 2022 | 강석윤, 김철호, 김태환, 신승수, 신유섭, 안미선, 오영택, 이현우, 장전엽, 최용원, 최진혁, 허재성 |
| 2022 | | Analysis of thromboembolic events in head and neck cancer patients who underwent concurrent chemoradiotherapy with cisplatin
The Korean journal of internal medicine, 37(3). : 653-659, 2022 | 강석윤, 김철호, 김태환, 신승수, 신유섭, 안미선, 오영택, 이현우, 장전엽, 최용원, 최진혁, 허재성 |
| 2022 | | Analysis of treatment outcomes according to the cycles of adjuvant chemotherapy in gastric cancer: a retrospective nationwide cohort study
BMC cancer, 22(1). : 948-948, 2022 | 강석윤, 김태환, 안미선, 이현우, 최용원, 최진혁 |
| 2022 | | Phase II study to investigate the efficacy of trastuzumab biosimilar (Herzuma®) plus treatment of physician's choice (TPC) in patients with heavily pretreated HER-2+ metastatic breast cancer (KCSG BR 18–14/KM10B)
Breast (Edinburgh, Scotland), 65. : 172-178, 2022 | 안미선 |
| 2022 | | Analysis of thromboembolic events in patients with non-small cell lung cancer who received adjuvant chemotherapy: single-center real-world data
Scientific reports, 12(1). : 7646-7646, 2022 | 강석윤, 김태환, 신승수, 안미선, 이현우, 최용원, 최진혁 |
| 2021 | | Factors to improve distress and fatigue in Cancer survivorship; further understanding through text analysis of interviews by machine learning
BMC cancer, 21(1). : 741-741, 2021 | 김지나, 안미선, 전미선 |
| 2021 | | Trastuzumab-based palliative chemotherapy for HER2-positive gastric cancer: a single-center real-world data
BMC cancer, 21(1). : 325-325, 2021 | 강석윤, 김태환, 신승수, 안미선, 이현우, 조헌도, 최용원, 최진혁 |
| 2021 | | Early removal of central venous catheter may not impact the in-hospital mortality in patients with acute leukemia
Annals of hematology, 100(11). : 2825-2830, 2021 | 강석윤, 김태환, 박준성, 안미선, 이현우, 정성현, 최용원, 최윤석, 최진혁 |
| 2021 | | Development of population-based cancer indicators and a measurement of cancer care continuum using a modified delphi method
Cancers, 13(19). : 4826-4826, 2021 | 박진희, 안미선, 전미선, 정승연, 조오연 |
| 2021 | | Clinicopathological and Molecular Analysis of 45 Cases of Pure Mucinous Breast Cancer
Frontiers in oncology, 10. : 558760-558760, 2021 | 강석윤, 김장희, 김태규, 노진, 안미선, 임현이, 정용식, 최진혁 |
| 2020 | | Erratum: Osimertinib for patients with non–small-cell lung cancer harboring uncommon EGFR mutations: A multicenter, open-label, phase II trial (KCSG-LU15-09) (Journal of Clinical Oncology (2020) DOI: 10.1200/JCO.19.00931)
Journal of clinical oncology, 38(11). : 1248-1248, 2020 | 안미선 |
| 2020 | | Phase II study of durvalumab and tremelimumab in pulmonary sarcomatoid carcinoma: KCSG-LU16-07
Thoracic cancer, 11(12). : 3482-3489, 2020 | 안미선 |
| 2020 | | Combination versus single-agent as palliative chemotherapy for gastric cancer
BMC cancer, 20(1). : 167-167, 2020 | 강석윤, 박준성, 신승수, 안미선, 이현우, 정성현, 최용원, 최진혁 |
| 2020 | | Osimertinib for Patients With Non-Small-Cell Lung Cancer Harboring Uncommon EGFR Mutations: A Multicenter, Open-Label, Phase II Trial (KCSG-LU15-09)
Journal of clinical oncology, 38(5). : 488-495, 2020 | 안미선 |
| 2019 | | The impact of systemic treatment on brain metastasis in patients with non-small-cell lung cancer: A retrospective nationwide population-based cohort study
Scientific reports, 9(1). : 18689-18689, 2019 | 강석윤, 안미선, 이현우 |
| 2019 | | Does the extent of brain metastasis affect outcome of non-small cell lung cancer patients treated with chemotherapy?
Journal of clinical oncology, 37(15_suppl). : e20616-e20616, 2019 | 강석윤, 안미선, 이현우, 최용원, 최진혁 |
| 2019 | | A Machine-Learning Approach Using PET-Based Radiomics to Predict the Histological Subtypes of Lung Cancer
Clinical nuclear medicine, 44(12). : 956-960, 2019 | 고영화, 안미선, 이수진 |
| 2019 | | The role of surgical resection before palliative chemotherapy in advanced gastric cancer
Scientific reports, 9. : 4136-4136, 2019 | 강석윤, 박준성, 손상용, 신승수, 안미선, 이현우, 정성현, 최용원, 최진혁, 한상욱, 허훈 |
| 2018 | | Should combination chemotherapy be used in all advanced gastric cancer patients?
Journal of clinical oncology, 36(15S). : e16081-e16081, 2018 | 강석윤, 안미선, 이현우, 최용원, 최진혁 |
| 2018 | | Prognostic significance of neutrophil lymphocyte ratio and platelet lymphocyte ratio in gastric cancer patients who underwent palliative chemotherapy
Journal of clinical oncology, 36(15S). : e16008-e16008, 2018 | 강석윤, 안미선, 이현우, 최용원, 최진혁 |
| 2018 | | 469: Therapy-induced senescence associated secretory phenotype enhances breast cancer cell invasion and stemness via CXCR1/2-CXCR1/2 ligands axis
Cancer research, 78(13S). : 469-469, 2018 | 강석윤, 박준성, 박태준, 안미선, 이현우, 정성현, 최용원, 최진혁 |
| 2018 | | Strong immunoexpression of dickkopf-1 is associated with response to bortezomib in multiple myeloma
Leukemia & lymphoma, 59(11). : 2670-2678, 2018 | 강석윤, 김장희, 박준성, 안미선, 이현우, 정성현, 최용원, 최진혁, 한재호 |
| 2018 | | The role of third-line chemotherapy in recurrent or metastatic gastric cancer: A cohort study with propensity score matching analysis
Medicine, 97(39). : e12588-e12588, 2018 | 강석윤, 박준성, 신승수, 안미선, 이현우, 정성현, 최용원, 최진혁 |
| 2016 | | Radiation Therapy-First Strategy After Surgery With or Without Adjuvant Chemotherapy in Stage IIIA-N2 Non-Small Cell Lung Cancer
International journal of radiation oncology, biology, physics, 94(3). : 621-627, 2016 | 노오규, 박래웅, 박성용, 안미선, 오영택, 윤덕용, 이현우, 전미선, 최진혁, 허재성 |
| 2016 | | High expression of Bcl-2 predicts poor outcome in diffuse large B-cell lymphoma patients with low international prognostic index receiving R-CHOP chemotherapy
International journal of hematology, 103(2). : 210-218, 2016 | 강석윤, 김장희, 박준성, 신승수, 안미선, 이현우, 정성현, 최용원, 최진혁, 한재호 |
| 2016 | | Baseline neutrophil-lymphocyte ratio is associated with baseline and subsequent presence of brain metastases in advanced non-small-cell lung cancer
Scientific reports, 6. : 38585-38585, 2016 | 고영화, 안미선, 이현우, 최용원, 최진혁 |
| 2015 | | Oral Maintenance Chemotherapy with 6-Mercaptopurine and Methotrexate in Patients with Acute Myeloid Leukemia Ineligible for Transplantation.
Journal of Korean medical science, 30(10). : 1416-1422, 2015 | 강석윤, 박준성, 안미선, 이현우, 정성현, 최용원, 최진혁 |
| 2015 | | Is fourth-line chemotherapy routine practice in advanced non-small cell lung cancer?
Lung cancer (Amsterdam, Netherlands), 87(2). : 155-161, 2015 | 강석윤, 박준성, 안미선, 이순영, 이현우, 정성현, 최용원, 최진혁 |
| 2015 | | Does the timing of adjuvant chemotherapy for gastric cancer influence patient outcome?
Acta oncologica (Stockholm, Sweden), 54(8). : 1231-1234, 2015 | 강석윤, 박준성, 신승수, 안미선, 이현우, 정성현, 조용관, 최용원, 최진혁, 한상욱, 한재호 |
| 2015 | | Phase II Trial of Nilotinib in Patients With Metastatic Malignant Melanoma Harboring KIT Gene Aberration: A Multicenter Trial of Korean Cancer Study Group (UN10-06).
The oncologist, 20(11). : 1312-1319, 2015 | 안미선 |
| 2014 | | Patterns of neutropenia and risk factors for febrile neutropenia of diffuse large B-cell lymphoma patients treated with rituximab-CHOP.
Journal of Korean medical science, 29(11). : 1493-1500, 2014 | 강석윤, 박준성, 안미선, 이현우, 정성현, 최용원, 최진혁 |
| 2014 | | Clinical significance of cryptic chromosomal translocations detected by multiplex RT-PCR in patients with acute leukemia.
International journal of laboratory hematology, 36(1). : e20-e23, 2014 | 강석윤, 박준성, 안미선, 이현우, 정성현, 조성란, 최진혁 |
